Skip to content

A prospective study on a novel traction device used for endoscopic submucosal dissection

A prospective study on a novel traction device used for endoscopic submucosal dissection

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200065925
Enrollment
Unknown
Registered
2022-11-18
Start date
2022-12-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

early carcinoma of digestive tract

Interventions

treatment group:using the novel traction device during the procedure

Sponsors

Chinese People’s Liberation Army General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. To be treated with ESD: (1) Esophageal lesions: >= 20 mm in size, clinically stage as cT1a or cT1b-SM1; (2) Gastric lesions: in accordance with Japanese gastric cancer treatment guidelines, clinically stage as cT1a, including differentiated adenocarcinoma, without ulcer; = 20 mm, difficult to achieve en bloc resection by EMR, and no submucosal invasion assessed by magnifying endoscopy; 2. Aged 18-80 years; 3. Written informed consent by the patient; 4. If the enrolled patient has more than one lesion removed by ESD, this study includes the largest one (1 lesion per patient).

Exclusion criteria

Exclusion criteria: 1. Impossible cessation of anticoagulant or antiplatelet medications; 2. Active infection; 3. Pregnancy or breastfeeding; 4. Ssevere mental disorder; 5. Unstable hypertension.

Design outcomes

Primary

MeasureTime frame
procedure time;

Secondary

MeasureTime frame
dissecting time;

Countries

China

Contacts

Public ContactChai Ningli

Chinese People’s Liberation Army General Hospital

csxlily@163.com+86 10 66937895

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026